SMSMED Stock Overview
Scandinavian Medical Solutions A/S deals in medical imaging equipment worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Scandinavian Medical Solutions A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.7.50 |
| 52 Week High | kr.12.35 |
| 52 Week Low | kr.6.56 |
| Beta | 0.44 |
| 1 Month Change | 1.35% |
| 3 Month Change | -4.09% |
| 1 Year Change | -30.23% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 33.33% |
Recent News & Updates
Shareholder Returns
| SMSMED | DK Healthcare | DK Market | |
|---|---|---|---|
| 7D | -1.3% | 1.7% | -2.2% |
| 1Y | -30.2% | -3.8% | 21.6% |
Return vs Industry: SMSMED underperformed the Danish Healthcare industry which returned -4.6% over the past year.
Return vs Market: SMSMED underperformed the Danish Market which returned 21.2% over the past year.
Price Volatility
| SMSMED volatility | |
|---|---|
| SMSMED Average Weekly Movement | 5.3% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in DK Market | 9.6% |
| 10% least volatile stocks in DK Market | 2.9% |
Stable Share Price: SMSMED has not had significant price volatility in the past 3 months.
Volatility Over Time: SMSMED's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 20 | Jens Paulsen | www.scandinavian-medical.com |
Scandinavian Medical Solutions A/S deals in medical imaging equipment worldwide. It offers equipment in the categories of CATH lab, CT, linear accelerator, mammography, PET/CT, SPECT/CT, X-ray, ultrasound, MRI, Gamma/SPECT, C-arm, mobile X-ray, R/F, and others, as well as provides CT, MRI, CATH lab, X-ray, MAMMO, PET/CT, and C-arm parts. The company also provides equipment rental and technical services.
Scandinavian Medical Solutions A/S Fundamentals Summary
| SMSMED fundamental statistics | |
|---|---|
| Market cap | kr.206.26m |
| Earnings (TTM) | kr.12.22m |
| Revenue (TTM) | kr.191.19m |
16.9x
P/E Ratio1.1x
P/S RatioIs SMSMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SMSMED income statement (TTM) | |
|---|---|
| Revenue | kr.191.19m |
| Cost of Revenue | kr.156.46m |
| Gross Profit | kr.34.73m |
| Other Expenses | kr.22.50m |
| Earnings | kr.12.22m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 18.16% |
| Net Profit Margin | 6.39% |
| Debt/Equity Ratio | 10.0% |
How did SMSMED perform over the long term?
See historical performance and comparison